Abstract

Optical monitoring of spent dialysate has been used to estimate the removal of water-soluble low molecular weight as well as protein-bound uremic toxins from the blood of end stage kidney disease (ESKD) patients. The aim of this work was to develop an optical method to estimate the removal of β2-microglobulin (β2M), a marker of middle molecule (MM) uremic toxins, during hemodialysis (HD) treatment. Ultraviolet (UV) and fluorescence spectra of dialysate samples were recorded from 88 dialysis sessions of 22 ESKD patients, receiving four different settings of dialysis treatments. Stepwise regression was used to obtain the best model for the assessment of β2M concentration in the spent dialysate. The correlation coefficient 0.958 and an accuracy of 0.000 ± 0.304 mg/L was achieved between laboratory and optically estimated β2M concentrations in spent dialysate for the entire cohort. Optically and laboratory estimated reduction ratio (RR) and total removed solute (TRS) of β2M were not statistically different (p > 0.35). Dialytic elimination of MM uremic toxin β2M can be followed optically during dialysis treatment of ESKD patients. The main contributors to the optical signal of the MM fraction in the spent dialysate were provisionally identified as tryptophan (Trp) in small peptides and proteins, and advanced glycation end-products.

Highlights

  • The removal of β2M is limited by intercompartmental mass transfer, an reduction ratio (RR) of 68 ± 2% was achieved in an earlier study of 10 patients with HDF in the post-dilution mode, calculated from pre- and post-treatment serum levels of β2M [33]

  • A mean total single session removal of β2M 204.9 ± 53.4 mg was observed by Brunati et al, using standard high-flux bicarbonate dialysis [34], which is similar to the value 228.6 ± 83.9 mg, achieved in this work using optical assessment technology combined with the total dialysate collection

  • Complicated mutual influences of chromophores and fluorophores in dialysate do not allow to attribute distinct excitation/emission wavelength pairs to specific fluorophores in the complex mixture of chromo- and fluorophores present in dialysate

Read more

Summary

Introduction

Licensee MDPI, Basel, Switzerland.Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 4.0/).The largest number of the end stage kidney disease (ESKD) patients are treated using hemodialysis (HD), which has remained one of the most expensive and time-consuming methods among the treatments of chronic diseases. Therefore, the monitoring of HD quality, related to the removal efficiency of the uremic solutes in dialysis, is important to ensure adequacy and cost-efficiency of the HD procedure [1,2]. Optical monitoring of the spent dialysate on the outflow from the dialysis machine is a promising alternative to dialysis adequacy estimation based on blood sampling [3]. While ultraviolet (UV)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call